Individual treatment heterogeneity in a three period two treatment cross-over design (Q2863750)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Individual treatment heterogeneity in a three period two treatment cross-over design |
scientific article; zbMATH DE number 6235501
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Individual treatment heterogeneity in a three period two treatment cross-over design |
scientific article; zbMATH DE number 6235501 |
Statements
3 December 2013
0 references
causal inference
0 references
clinical trials
0 references
counterfactual
0 references
potential outcomes
0 references
subject-treatment interactions
0 references
Individual treatment heterogeneity in a three period two treatment cross-over design (English)
0 references
0.7679389119148254
0 references
0.7641451954841614
0 references
0.7623530030250549
0 references
0.7623530030250549
0 references
